Published in Vopr Virusol on June 20, 1975
Evaluation of amantadine in artificially induced A2 and B influenza. JAMA (1970) 1.24
Study of rimantadine in the USSR: a review of the literature. Rev Infect Dis (1981) 1.02
Non-tuberculosis mycobacteria in Africa. 1. Isolation and identification. Bull World Health Organ (1967) 1.01
Secretory anti-influenza immunity. Adv Immunol (1976) 0.99
Non-tuberculosis mycobacteria in Africa. 2. Sensitivity to mycobacteriophages. Bull World Health Organ (1967) 0.95
The prophylactic effectiveness of amantadine hydrochloride in an epidemic of Hong Kong influenza in Leningrad in 1969. Bull World Health Organ (1970) 0.89
Non-tuberculosis mycobacteria in Africa. 3. Formamidase activity--its evaluation and practical application. Bull World Health Organ (1967) 0.88
The importance of virus drug-resistance in the treatment of influenza with rimantadine. Antiviral Res (1989) 0.88
Formation of secretory and circulating antibodies after immunization with live and inactivated influenza virus vaccines. J Infect Dis (1977) 0.86
Some problems of modern influenza prophylaxis with live vaccine. J Infect Dis (1977) 0.83
[Distribution of myosin in a primary culture of human aortic intimal cells]. Biull Eksp Biol Med (1984) 0.79
The kaolin agglutination test with three antigens used for detecting circulating antibodies against tuberculosis in humans, cattle and guinea-pigs. Tubercle (1967) 0.78
Modulation of humoral immune response to influenza vaccines by BCG. Acta Virol (1985) 0.78
[An experience of the use of stem cells in the treatment of patients with myocardial infarction and low ejection fraction]. Kardiologiia (2009) 0.77
Associated seroconversions to respiratory viruses in volunteers with experimental influenza infection. Acta Virol (1976) 0.77
T lymphocytes as an indicator in influenza vaccination, influenza and acute respiratory diseases. Acta Virol (1978) 0.76
[Influenza vaccination of patients with pulmonary tuberculosis in the tuberculosis dispensary]. Probl Tuberk (1983) 0.75
[Vaccination against influenza in pulmonary tuberculosis patients]. Probl Tuberk (1980) 0.75
A serological test in tuberculosis. A "blind" trial of the kaolin-agglutination test (KAT) for detection of tuberculosis antibodies. Bull World Health Organ (1966) 0.75
[Dynamics of the antihemagglutinin level in annual human immunization with inactivated influenza vaccines]. Vopr Virusol (1986) 0.75
The present and future of specific prophylaxis of influenza and other acute viral respiratory diseases. Am Rev Respir Dis (1974) 0.75
[Changes in the activity of total lactate dehydrogenase and its isoenzymes in patients with influenza A 2 (Hong Kong), other acute respiratory diseases and viral pneumonia]. Vrach Delo (1973) 0.75
[Preventive and therapeutic action of amantadine in acute respiratory diseases]. Voen Med Zh (1970) 0.75
Characteristics of antigenic and biological properties of influenza A viruses isolated different epidemics of the same cycle. Ann Microbiol (Paris) (1975) 0.75
[Effectiveness of amantadine hydrochloride (midantane) in prevention of artificially induced influenza]. Vopr Virusol (1972) 0.75
Characteristics of Mycobacterium tuberculosis in Africa. Vulnerable and invulnerable types of drug resistance. Am Rev Respir Dis (1972) 0.75
Kaolin agglutination test in diagnosis of tuberculosis in Kenya. Tubercle (1966) 0.75
Characteristics of African M. tuberculosis. Jpn J Tuberc Chest Dis (1970) 0.75
[Primary drug resistance in tuberculosis]. Sov Med (1970) 0.75
[Protecting tuberculosis patients against influenza]. Feldsher Akush (1984) 0.75
[State of the blood coagulation and anticoagulation system in radiation therapy of lung cancer]. Vopr Onkol (1971) 0.75
BCG vaccine responses following simultaneous immunization against influenza and tuberculosis. 2nd report. Z Erkr Atmungsorgane (1981) 0.75
Routine diagnosis of tuberculosis with phase-contrast microscopy. Am Rev Respir Dis (1974) 0.75
Characteristics of African Mycobacterium tuberculosis. Constancy of drug susceptibility in laboratory animals. Am Rev Respir Dis (1973) 0.75
[Blood coagulation in chronic pneumonia]. Ter Arkh (1972) 0.75
Subunit influenza virus vaccine Grippovac SE-AZh (vaccination of adults). Acta Virol (1985) 0.75
Phase-contrast microscopy in diagnosis of tuberculosis. Am Rev Respir Dis (1973) 0.75
[Chemoprophylaxis of influenza with amantadine hydrochloride]. Vestn Akad Med Nauk SSSR (1970) 0.75
[Virulence of Mycobacterium tuberculosis isolated in the far north]. Probl Tuberk (1984) 0.75
Influenza vaccine response following its simultaneous application with BCG 1st report. Z Erkr Atmungsorgane (1981) 0.75
[Possibilities for spring vaccination of schoolchildren against influenza]. Zh Mikrobiol Epidemiol Immunobiol (1985) 0.75
[Protection of the elderly against influenza (a review of the literature)]. Vrach Delo (1981) 0.75
[World-wide distribution, isolation and classification of mycobacteria. I. Distribution, frequency and methods of isolation]. Zh Mikrobiol Epidemiol Immunobiol (1966) 0.75
[State of the coagulation and anticagulation system in acute pneumonia]. Sov Med (1971) 0.75
[Catalase positive nature of African cultures of tuberculosis mycobacteria resistant to isoniazid and other preparations]. Zh Mikrobiol Epidemiol Immunobiol (1966) 0.75
[Chemoprevention and chemotherapy of influenza and other virus diseases (review of the problem)]. Ter Arkh (1972) 0.75
[Comparative evaluation of the reactogenicity and antigenic activity of Soviet inactivated influenza vaccines]. Zh Mikrobiol Epidemiol Immunobiol (1984) 0.75
[Soviet mycobacteriology today]. Sov Med (1984) 0.75
[Experimental tuberculous meningoencephalitis in guinea pigs following their inoculation with diverse strains of M. tuberculosis var. hominis]. Probl Tuberk (1970) 0.75
[Etiological role of respiratory viruses in patients with chronic pneumonia]. Ter Arkh (1971) 0.75
[Treatment with proteolytic enzymes of some lung diseases]. Ter Arkh (1965) 0.75
Tuberculosis in Africans. Prolonged observations on drug sensitivity of M. tuberculosis during chemotherapy. Pneumonologie (1974) 0.75
Subunit influenza vaccine and its testing in clinical immunology. J Hyg Epidemiol Microbiol Immunol (1980) 0.75
[Anti-phosphatide antibodies in tuberculosis]. Veterinariia (1971) 0.75
[Present status of the problem of vaccinoprophylaxis against influenza and acute respiratory diseases]. Vestn Akad Med Nauk SSSR (1975) 0.75
[The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes]. Zh Nevropatol Psikhiatr Im S S Korsakova (1973) 0.75
[Clinical characteristics and general principles of treatment of viral pneumonias]. Ter Arkh (1972) 0.75
[Vaccinal prevention of influenza in children]. Tr Inst Im Pastera (1982) 0.75
[The use of garlic phytoncides in the treatment of patients with different inflammatory diseases of the respiratory organs]. Sov Med (1965) 0.75
Drug resistance and speed of growth of M. tuberculosis. I. Growth on drug-free medium. Jpn J Tuberc Chest Dis (1971) 0.75
[Indices of hemostasis in radiotherapy of cancer of the lung]. Med Radiol (Mosk) (1970) 0.75
[Selection of a method of preserving pathological material from tuberculosis patients for transport in the Far North]. Lab Delo (1983) 0.75
[Clinical peculiarities of type A2 Hong Kong influenza in 1969]. Klin Med (Mosk) (1970) 0.75
Enhancement of protection against influenza by complex prophylactic schemes. J Hyg Epidemiol Microbiol Immunol (1980) 0.75
Search for optimal scheme for administering live allantoic influenza vaccine. J Hyg Epidemiol Microbiol Immunol (1983) 0.75
[Influenza and tuberculosis]. Probl Tuberk (1984) 0.75
Virulence of multidrugresistant Mycobacterium tuberculosis. Exp Pathol (Jena) (1973) 0.75
[The therapeutic effectiveness of IZAVR-2 in influenza]. Vrach Delo (1972) 0.75
[Modern protection from influenza]. Feldsher Akush (1982) 0.75
[Vaccine prophylaxis of influenza in persons with chronic pathology]. Zh Mikrobiol Epidemiol Immunobiol (1982) 0.75
[Prevention and treatment of influenza]. Klin Med (Mosk) (1972) 0.75
[Pathomorphology of experimental tuberculosis with varying drug resistance and catalase activity of the causative agent]. Probl Tuberk (1972) 0.75
[Results of clinical studies on the prophylactic and therapeutic effectiveness of oxoline on artificially induced influenza A2 infection in volunteers]. Farmakol Toksikol (1971) 0.75
[Bacteriological diagnosis of tuberculosis under conditions of hot climate. 3. Typing of Mycobacterium by means of niacin test]. Lab Delo (1967) 0.75
[Interferon and prevention of influenza]. Feldsher Akush (1984) 0.75
[Fast diagnosis of pneumonia pathogens]. Vrach Delo (1971) 0.75
[Treatment of early pneumonia in influenzae]. Klin Med (Mosk) (1971) 0.75
[Dynamics of drug resistance of tuberculosis mycobacteria in long-term chemotherapy]. Sov Med (1971) 0.75
[Simultaneous vaccination against influenza A and tuberculosis]. Zh Mikrobiol Epidemiol Immunobiol (1983) 0.75
[Role of infection in the pathogenesis of bronchial asthma]. Vrach Delo (1966) 0.75
[Bacteriological diagnosis of tuberculosis under the conditions of a hot climate]. Lab Delo (1966) 0.75
[Cross protection in mice immunized with different anti-influenza preparations]. Vopr Virusol (1982) 0.75
[Rapid methods of determining aspartate aminotransferase and lactate dehydrogenase activity in first aid and emergency medical service]. Sov Med (1968) 0.75
[The use of aerosols of nystatin sodium salt]. Klin Med (Mosk) (1965) 0.75
[Clinical features of uncomplicated and complicated influenza in the A2-Hong Kong epidemic of 1969]. Vestn Akad Med Nauk SSSR (1970) 0.75
Perspectives of cooperation of CMEA countries in combatting influenza. J Hyg Epidemiol Microbiol Immunol (1982) 0.75
[Worldwide distribution, isolation and classification of Mycobacteria. II. Classification and methods of identification]. Zh Mikrobiol Epidemiol Immunobiol (1966) 0.75
[A study of the phage lysability of mycobacteria isolated in Africa]. Zh Mikrobiol Epidemiol Immunobiol (1966) 0.75
[Mycobacteriosis and its causative agents]. Feldsher Akush (1983) 0.75
Experimental tuberculosis with African strains of various drug-resistance. Exp Pathol (Jena) (1972) 0.75
[Virulence of catalase positive Mycobacterium tuberculosis with various characteristics of drug resistance]. Lab Delo (1971) 0.75
[Evaluation of Mycobacterium tuberculosis virulence by the intracerebral infection of guinea pigs]. Probl Tuberk (1985) 0.75
An express method for measuring the virulence of Mycobacterium tuberculosis. J Hyg Epidemiol Microbiol Immunol (1972) 0.75
Simultaneous application of influenza chemovaccine and "Vaxigrip" preparations with BCG. Acta Virol (1983) 0.75
[Experience in using inactivated influenza vaccine with persons at "high risk"]. Tr Inst Im Pastera (1979) 0.75
Basic principles and stages in testing new vaccines against respiratory viruses. Am Rev Respir Dis (1976) 0.75
[Methods and forms of procedures of faculties for increasing the qualifications of medical school teachers]. Sov Zdravookhr (1972) 0.75
[Evaluation of the postvaccination level of influenza antibodies by means of the radial immunodiffusion and hemagglutination inhibition reactions]. Vopr Virusol (1976) 0.75
[Treatment of patients with chronic pneumonia]. Ter Arkh (1973) 0.75
Drug resistance and speed of growth of M. tuberculosis. 2. Vulnerable and invulnerable types of resistance. Jpn J Tuberc Chest Dis (1971) 0.75